XPHYF News and Press, XPhyto Therapeutics Corp From 04/21/21

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) today announced its entry into an agreement with an established German pharmaceutical wholesaler and service provider for the distribution, storage and logistics of XPhyto's diagnostic products in Germany. According to the update, t...

VANCOUVER, BC / ACCESSWIRE / April 21, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company") is pleased to announce that it has entered into an agreement (the "Agreement") with an established German pharmaceutical wholesaler and service provider (t...

The Fireside Project is set to launch the first psychedelics peer support hotline in the world. Its creator, Joshua White, revealed that the concept behind the support line was to offer support to people who are experiencing an intense psychedelic trip or those who want to process an int...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities, has appointed two new positions at XP Diagnostics GmbH, its wholly owned Ger...

VANCOUVER, BC / ACCESSWIRE / April 20, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of Mr. Wolfgang Probst as the Chief Operations Officer (COO) of XPhyto and the addition of Mr. Manfred Buchberger as t...

A new study conducted by researchers from the University of Virginia Cancer Center may be the key to better immunotherapies for the treatment of solid tumors caused by triple-negative breast cancer, colon cancer and ovarian cancer; these cancers were found to be effective in lab tests but ...

Although more than 30 states have legalized some form of cannabis, the drug still remains illegal at the federal level. So while people in states with legal cannabis markets can consume cannabis legally, they are still liable to federal repercussions in certain situations. This is especi...

With psychedelics going mainstream, it should come as no surprise that researchers are planning to conduct a trial evaluating the treatment of alcohol use disorder using psilocybin, which is commonly known as a magic mushroom. Director of the Pacific Neuroscience Institute Daniel Kelly, ...

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to l...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience technology accelerator, is set to launch a solution for improving detection of the virus responsible for the worldwide pandemic. The company recently announced European regulatory approval of its point-of-care SARS-CoV...